Serious but rare risks include pancreatitis, gallbladder events, and potential thyroid concerns (based on animal data)
(Physicians will likely stop prescribing a GLP-1 or dual agonist if you receive a pancreatitis diagnosis.) Your doctor should also reevaluate treatment and dosage if you have any other severe side effects
However, while central pharmacodynamics is an important factor influencing drug intake, peripheral pharmacokinetics can also have a profound effect on intake and even neural response to the same drug 56,57
Xie Y-H, Chen Y-X, Fang J-Y
Tirzepatide injections (at $289/mo month-to-month, or from $249/mo on the 6-month plan) bind both GLP-1 and GIP receptors, showing slightly greater weight reduction in head-to-head trialsapproximately 2-4% additional lossthough individual response varies significantly based on genetic factors